L. Robert Guenthner

$1 billion available for emerging growth life sciences companies through health care reform

USA - April 12 2010 The recently enacted landmark health care reform legislation, H.R. 3590, the Patient Protection and Affordable Care Act, appropriates up to $1 billion in tax credits and cash grants for small and mid-sized life sciences companies to defray the costs of investment in qualifying therapeutic discovery projects undertaken in 2009 and 2010.

Jeffrey A. Baumel, Victor H. Boyajian, Bret Koplow, Ira L. Kotel